Newly Approved Weight Loss Drug - Search News

weight loss, Compound versions of drugs

Compound versions of some weight loss drugs to be restricted

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available after a decision by the U.S. Food and Drug Administration. The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply.

MarketWatch on MSN · 2d

Here’s why Ozempic maker’s new weight-loss drug isn’t good enough for investors

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Newsweek on MSN · 4d

New Discovery Promises Weight Loss Without Ozempic's Side Effects

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of semaglutide.

1d

Data on new Novo Nordisk obesity drug disappoints in trial, shares drop

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

FoodNavigator1d

GLP-1 challenger claims weight loss while maintaining muscle

Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications ...

6d

Amgen (NASDAQ:AMGN) Enters Late-Stage Testing on Weight Loss Drug

We know that weight loss drugs have been big winners for the companies that produce them. And now, biotech stock Amgen (AMGN) ...

1d

Eli Lilly's first weight loss pill could expand access to GLP-1s around the globe, executive says

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results